Skip to main content
Fig. 6 | EJNMMI Physics

Fig. 6

From: Dosimetric impact of Ac-227 in accelerator-produced Ac-225 for alpha-emitter radiopharmaceutical therapy of patients with hematological malignancies: a pharmacokinetic modeling analysis

Fig. 6

Total absorbed dose to tissue from 1 MBq administration of 225/7Ac-labeled anti-CD33 antibody in patients with leukemia. The left axis gives the absorbed dose (blue bars) from 225Ac and all daughters. The right axis is the 227Ac to 225Ac absorbed dose (including daughters) ratio (grey bars)

Back to article page